Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Muller

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology|June 20, 2022
Multiple imputation to minimise bias from missing stage information in estimates of early cancer diagnosis in England: a population-based studyPatrick Muller, Laura Woods
IEEE Transactions on Pattern Analysis and Machine Intelligence|October 16, 2025
Examining the Impact of Optical Aberrations to Image Classification and Object Detection ModelsPatrick Muller, Alexander Braun, Margret Keuper
Cancer Epidemiology|June 15, 2020
Temporal and geographic changes in stage at diagnosis in England during 2008-2013: A population-based study of colorectal, lung and ovarian cancersPatrick Muller, Laura Woods, Sarah Walters
The Journal of Biological Chemistry|June 25, 2002
The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expressionPatrick Muller, Silke Kietz, Jan-Ake Gustafsson, et al.
American Journal of Surgery|May 2, 2006
Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulationJennifer R Garreau, Patrick Muller, Rodney Pommier, et al.
Cancer Epidemiology|July 30, 2018
Which indicators of early cancer diagnosis from population-based data sources are associated with short-term mortality and survival?Patrick Muller, Sarah Walters, Michel P Coleman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 14, 2004
Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic toolSuEllen Toth-Fejel, Julie Cheek, Kristine Calhoun, et al.
Trials|July 18, 2020
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis planPatrick Muller, Kashfia Chowdhury, Caroline Gordon, et al.
Foot (Edinburgh, Scotland)|April 23, 2022
Patient reported outcome measures in ankle replacement versus ankle arthrodesis - A systematic reviewSarveen Gajebasia, Toby Jennison, James Blackstone, et al.
World Journal of Surgery|April 13, 2007
A new hormonal therapy for estrogen receptor-negative breast cancerChelsea Hardin, Rodney Pommier, Kristine Calhoun, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology|June 20, 2022
Multiple imputation to minimise bias from missing stage information in estimates of early cancer diagnosis in England: a population-based studyPatrick Muller, Laura Woods
IEEE Transactions on Pattern Analysis and Machine Intelligence|October 16, 2025
Examining the Impact of Optical Aberrations to Image Classification and Object Detection ModelsPatrick Muller, Alexander Braun, Margret Keuper
Cancer Epidemiology|June 15, 2020
Temporal and geographic changes in stage at diagnosis in England during 2008-2013: A population-based study of colorectal, lung and ovarian cancersPatrick Muller, Laura Woods, Sarah Walters
The Journal of Biological Chemistry|June 25, 2002
The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expressionPatrick Muller, Silke Kietz, Jan-Ake Gustafsson, et al.
American Journal of Surgery|May 2, 2006
Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulationJennifer R Garreau, Patrick Muller, Rodney Pommier, et al.
Cancer Epidemiology|July 30, 2018
Which indicators of early cancer diagnosis from population-based data sources are associated with short-term mortality and survival?Patrick Muller, Sarah Walters, Michel P Coleman, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 14, 2004
Estrogen and androgen receptors as comediators of breast cancer cell proliferation: providing a new therapeutic toolSuEllen Toth-Fejel, Julie Cheek, Kristine Calhoun, et al.
Trials|July 18, 2020
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis planPatrick Muller, Kashfia Chowdhury, Caroline Gordon, et al.
Foot (Edinburgh, Scotland)|April 23, 2022
Patient reported outcome measures in ankle replacement versus ankle arthrodesis - A systematic reviewSarveen Gajebasia, Toby Jennison, James Blackstone, et al.
World Journal of Surgery|April 13, 2007
A new hormonal therapy for estrogen receptor-negative breast cancerChelsea Hardin, Rodney Pommier, Kristine Calhoun, et al.
Pageof 4